Latest publications

H-1 Parvovirus as a Cancer-Killing Agent: Past, Present, and Future.

  • Laboratory of Oncolytic-Virus-Immuno-Therapeutics
June 18, 2019
2019 Jun. Viruses.11(6).
By:
  • Bretscher C
  • Marchini A.

Cholestasis induced liver pathology results in dysfunctional immune responses after arenavirus infection.

  • Laboratory of Oncolytic-Virus-Immuno-Therapeutics
September 15, 2018
2018 Sep. Sci Rep.8(1):12179.
By:
  • Lang E
  • Pozdeev VI
  • Shinde PV
  • Xu HC
  • Sundaram B
  • Zhuang Y
  • Poschmann G
  • Huang J
  • Stuhler K
  • Pandyra AA
  • Keitel V
  • Haussinger D
  • Lang KS
  • Lang PA.

Inhibition of HIF1alpha-dependent upregulation of Phospho-l-Plastin resensitizes multiple myeloma cells to frontline therapy.

  • Tumor Microenvironment
  • Bioinformatics and Modelling
  • Laboratory of Oncolytic-Virus-Immuno-Therapeutics
May 23, 2018
2018 May. Int J Mol Sci.19(6):1551.
By:
  • Bosseler M
  • Marani V
  • Broukou A
  • Lequeux A
  • Kaoma T
  • Schlesser V
  • Francois JH
  • Palissot V
  • Berchem GJ
  • Aouali N
  • Janji B.

Virotherapy Research in Germany: From Engineering to Translation.

  • Laboratory of Oncolytic-Virus-Immuno-Therapeutics
October 01, 2017
2017 Oct. Hum Gene Ther.28(10):800-819.
By:
  • Ungerechts G
  • Engeland CE
  • Buchholz CJ
  • Eberle J
  • Fechner H
  • Geletneky K
  • Holm PS
  • Kreppel F
  • Kuhnel F
  • Lang KS
  • Leber MF
  • Marchini A
  • Moehler M
  • Muhlebach MD
  • Rommelaere J
  • Springfeld C
  • Lauer UM
  • Nettelbeck DM.

A Track Record on SHOX: From Basic Research to Complex Models and Therapy.

  • Laboratory of Oncolytic-Virus-Immuno-Therapeutics
September 01, 2016
2016 Sep. Endocr Rev.37(4):417-48. Epub 2016 Jun 29.
By:
  • Marchini A
  • Ogata T
  • Rappold GA.

A high rate of telomeric sister chromatid exchange occurs in chronic lymphocytic leukaemia B-cells.

  • Laboratory of Oncolytic-Virus-Immuno-Therapeutics
July 01, 2016
2016 Jul. Br J Haematol.174(1):57-70. Epub 2016 Mar 11.
By:
  • Medves S
  • Auchter M
  • Chambeau L
  • Gazzo S
  • Poncet D
  • Grangier B
  • Verney A
  • Moussay E
  • Ammerlaan W
  • Brisou G
  • Morjani H
  • Geli V
  • Palissot V
  • Berchem G
  • Salles G
  • Wenner T.

Epigenetic activity of peroxisome proliferator-activated receptor gamma agonists increases the anticancer effect of histone deacetylase inhibitors on multiple myeloma cells.

  • Tumor Microenvironment
  • In vivo imaging facility
  • Laboratory of Oncolytic-Virus-Immuno-Therapeutics
June 19, 2015
2015 Jun. PLoS One.10(6):e0130339.
By:
  • Aouali N
  • Broukou A
  • Bosseler M
  • Keunen O
  • Schlesser V
  • Janji B
  • Palissot V
  • Stordeur P
  • Berchem G.

Oncolytic parvoviruses: from basic virology to clinical applications.

  • Laboratory of Oncolytic-Virus-Immuno-Therapeutics
January 29, 2015
2015 Jan. Virol J.12:6.
By:
  • Marchini A
  • Bonifati S
  • Scott EM
  • Angelova AL
  • Rommelaere J.

Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas.

  • Laboratory of Oncolytic-Virus-Immuno-Therapeutics
October 01, 2013
2013 Oct. EMBO Mol Med.5(10):1537-55. Epub 2013 Sep 17.
By:
  • Li J
  • Bonifati S
  • Hristov G
  • Marttila T
  • Valmary-Degano S
  • Stanzel S
  • Schnolzer M
  • Mougin C
  • Aprahamian M
  • Grekova SP
  • Raykov Z
  • Rommelaere J
  • Marchini A.

Generation of an adenovirus-parvovirus chimera with enhanced oncolytic potential.

  • Laboratory of Oncolytic-Virus-Immuno-Therapeutics
October 01, 2012
2012 Oct. J Virol.86(19):10418-31. Epub 2012 Jul 11.
By:
  • El-Andaloussi N
  • Bonifati S
  • Kaufmann JK
  • Mailly L
  • Daeffler L
  • Deryckere F
  • Nettelbeck DM
  • Rommelaere J
  • Marchini A.

Molecular pathways: rodent parvoviruses--mechanisms of oncolysis and prospects for clinical cancer treatment.

  • Laboratory of Oncolytic-Virus-Immuno-Therapeutics
July 01, 2012
2012 Jul. Clin Cancer Res.18(13):3516-23. Epub 2012 May 7.
By:
  • Nuesch JP
  • Lacroix J
  • Marchini A
  • Rommelaere J.

Through its nonstructural protein NS1, parvovirus H-1 induces apoptosis via accumulation of reactive oxygen species.

  • Laboratory of Oncolytic-Virus-Immuno-Therapeutics
June 01, 2010
2010 Jun. J Virol.84(12):5909-22. Epub 2010 Apr 7.
By:
  • Hristov G
  • Kramer M
  • Li J
  • El-Andaloussi N
  • Mora R
  • Daeffler L
  • Zentgraf H
  • Rommelaere J
  • Marchini A.